As of January 22, 2025, Vericel (VCEL) has a market cap of $2.91 billion USD. According to our data, Vericel is ranked No.3529 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $2.91 B |
7.42%
|
Dec 31, 2024 | $2.71 B |
54.20%
|
Dec 29, 2023 | $1.76 B |
35.19%
|
Dec 30, 2022 | $1.30 B |
-32.98%
|
Dec 31, 2021 | $1.94 B |
27.27%
|
Dec 31, 2020 | $1.52 B |
77.47%
|
Dec 31, 2019 | $0.86 B |
0.00%
|
Dec 31, 2018 | $0.86 B |
219.27%
|
Dec 29, 2017 | $0.27 B |
81.67%
|
Dec 30, 2016 | $0.15 B |
16.28%
|
Dec 31, 2015 | $0.13 B |
-15.13%
|
Dec 31, 2014 | $0.15 B |
-5.88%
|
Dec 31, 2013 | $0.16 B |
-87.18%
|
Dec 31, 2012 | $1.24 B |
-30.77%
|
Dec 30, 2011 | $1.80 B |
-28.91%
|
Dec 31, 2010 | $2.53 B |
3.23%
|
Dec 31, 2009 | $2.45 B |
-38.00%
|
Dec 31, 2008 | $3.95 B |
-3.85%
|
Dec 31, 2007 | $4.11 B |
-57.72%
|
Dec 29, 2006 | $9.71 B |
-41.71%
|
Dec 30, 2005 | $16.66 B |
48.59%
|
Dec 31, 2004 | $11.21 B |
6.77%
|
Dec 31, 2003 | $10.50 B |
182.98%
|
Dec 31, 2002 | $3.71 B |
-52.04%
|
Dec 31, 2001 | $7.74 B |
12.00%
|
Dec 29, 2000 | $6.91 B |
12.00%
|
Dec 31, 1999 | $6.17 B |
-72.83%
|
Dec 31, 1998 | $22.70 B |
-34.29%
|
Dec 31, 1997 | $34.55 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Organogenesis
ORGO
|
$0.44 B |
-0.000 M
|
USA
|
MiMedx Group
MDXG
|
$1.34 B |
-0.000 M
|
USA
|
Integra LifeSciences
IART
|
$1.94 B |
3.858 M
|
USA
|
Smith & Nephew
SNN
|
$11.01 B |
-0.000 M
|
UK
|
Zimmer Biomet
ZBH
|
$21.97 B |
-0.000 M
|
USA
|
Stryker Corporation
SYK
|
$149.34 B |
-0.003 M
|
USA
|
Medtronic
MDT
|
$113.01 B |
0.000 M
|
Ireland
|
Johnson & Johnson
JNJ
|
$347.78 B |
-0.005 M
|
USA
|
Baxter
BAX
|
$16.26 B |
-0.000 M
|
USA
|
Boston Scientific
BSX
|
$149.05 B |
0.001 M
|
USA
|
Abbott Laboratories
ABT
|
$204.27 B |
0.004 M
|
USA
|
Edwards Lifesciences
EW
|
$40.69 B |
0.000 M
|
USA
|
Orthofix Medical
OFIX
|
$0.70 B |
-0.000 M
|
USA
|
Market Cap | = | VCEL Stock Price | * | VCEL Shares Outstanding |
= | $58.99 | * | 49.36 M | |
= | $2.91 B |